0
Correspondence |

Are CHEST Guidelines Global in Coverage?CHEST Guidelines Are Not Global: Probably Not FREE TO VIEW

Inderpaul Singh Sehgal, MD, DM; Ritesh Agarwal, MD, DM, FCCP
Author and Funding Information

From the Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research.

CORRESPONDENCE TO: Inderpaul Singh Sehgal, MD, DM, Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Sector-12, Chandigarh-160012, India; e-mail: ipdoc_2000@hotmail.com


FINANCIAL/NONFINANCIAL DISCLOSURES: The authors have reported to CHEST that no potential conflicts of interest exist with any companies/organizations whose products or services may be discussed in this article.

Reproduction of this article is prohibited without written permission from the American College of Chest Physicians. See online for more details.


Chest. 2015;147(5):e190. doi:10.1378/chest.15-0070
Text Size: A A A
Published online
To the Editor:

We read with interest the point/counterpoint editorials in a recent issue of CHEST (January 2015)1,2 debating whether American College of Chest Physicians (CHEST) guidelines are global in coverage. Although we agree that evidence-based guidelines formulated by leading international societies cover a vast array of respiratory disorders and are drafted after a thorough review of literature, they may not be applicable and practical at all centers, especially resource-limited settings. For example, the international evidence-based Infectious Diseases Society of America/American Thoracic Society guidelines for the management of community-acquired pneumonia (CAP)3 endorse the use of respiratory fluoroquinolones for management of CAP in patients with comorbidities and those who have received antibiotics within 3 months. However, this cannot be extrapolated to the Indian population where TB is endemic and continues to be an important health issue.

Respiratory fluoroquinolones are an integral component for the treatment of drug-resistant TB. Such a recommendation is likely to cause indiscriminative use of quinolones for treatment of community-acquired respiratory tract infections.4 The prior use of quinolones can lead to an increased risk of acquiring infection with drug-resistant Mycobacterium tuberculosis, thus adding to the burden of drug-resistant TB.5 In recent pneumonia guidelines, we have discouraged the indiscriminate use of quinolones in routine management of CAP, reserving its use for treatment of drug-resistant TB.6 In similar fashion, we have also recommended against the use of linezolid for nosocomial pneumonia, reserving its use for drug-resistant TB.6,7 The international guidelines also recommend the use of investigations like measurement of urinary antigen for diagnosis of Streptococcus pneumoniae and Legionella pneumonia. This is not practical for developing countries like India, as these investigations are either not freely available or are too expensive to be used routinely.

Hence, we feel that although the international guidelines including CHEST guidelines are evidence-based and robust, they need to be modified by national chest societies to better suit their population.

References

Nathanson I, Ouellette DR. POINT: are the CHEST guidelines global in coverage? Yes. Chest. 2015;147(1):11-13. [CrossRef] [PubMed]
 
Mehta AC, Banga A, Stoller JK. COUNTERPOINT: are the CHEST guidelines global in coverage? No. Chest. 2015;147(1):13-15. [CrossRef] [PubMed]
 
Mandell LA, Wunderink RG, Anzueto A, et al; Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27-S72. [CrossRef] [PubMed]
 
Adriaenssens N, Coenen S, Versporten A, et al; ESAC Project Group. European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997-2009). J Antimicrob Chemother. 2011;66(suppl 6):vi47-vi56. [PubMed]
 
Migliori GB, Langendam MW, D’Ambrosio L, et al. Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones. Eur Respir J. 2012;40(4):814-822. [CrossRef] [PubMed]
 
Gupta D, Agarwal R, Aggarwal AN, et al; Pneumonia Guidelines Working Group. Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: joint ICS/NCCP(I) recommendations. Lung India. 2012;29(suppl 2):S27-S62. [CrossRef] [PubMed]
 
Dhooria S, Agarwal R, Behera D. Linezolid for extensively drug-resistant tuberculosis. N Engl J Med. 2013;368(3):290-291. [CrossRef] [PubMed]
 

Figures

Tables

References

Nathanson I, Ouellette DR. POINT: are the CHEST guidelines global in coverage? Yes. Chest. 2015;147(1):11-13. [CrossRef] [PubMed]
 
Mehta AC, Banga A, Stoller JK. COUNTERPOINT: are the CHEST guidelines global in coverage? No. Chest. 2015;147(1):13-15. [CrossRef] [PubMed]
 
Mandell LA, Wunderink RG, Anzueto A, et al; Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27-S72. [CrossRef] [PubMed]
 
Adriaenssens N, Coenen S, Versporten A, et al; ESAC Project Group. European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997-2009). J Antimicrob Chemother. 2011;66(suppl 6):vi47-vi56. [PubMed]
 
Migliori GB, Langendam MW, D’Ambrosio L, et al. Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones. Eur Respir J. 2012;40(4):814-822. [CrossRef] [PubMed]
 
Gupta D, Agarwal R, Aggarwal AN, et al; Pneumonia Guidelines Working Group. Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: joint ICS/NCCP(I) recommendations. Lung India. 2012;29(suppl 2):S27-S62. [CrossRef] [PubMed]
 
Dhooria S, Agarwal R, Behera D. Linezolid for extensively drug-resistant tuberculosis. N Engl J Med. 2013;368(3):290-291. [CrossRef] [PubMed]
 
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543